<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Activity of Research-Grade Pemivibart against SARS-CoV-2 Sublineages</title>

    <link rel="stylesheet" href="style.css">
</head>
<body>
    <ul>
        <li class="res">CORRESPONDENCE</li>
        <li class="whi">|</li>
        <li>NOV 13, 2024</li>
        <li class="whi">|</li>
        <li>FREE</li>
    </ul>
    <div>
        <div>
            <img src="chart (1).png" alt="covid">
        </div>
        <div>
           <p class="head">Activity of Research-Grade Pemivibart against SARS-CoV-2 Sublineages</p>  

           <p>Q. Wang and Others</p>
    
            <p>SARS-CoV-2 continues to evolve under immunologic pressure. A synthesized version of pemivebart, an anti-SARS-CoV-2
        monoclonal antibody with recent emergency-use authorization, showed mixed activity against emerging variants.</p>

            <p class="cor"><b>Correction</b> Pemivibart Activity against recent SARS-CoV-2 JN.1 Sublineages </p>
        </div>
    </div>
</body>
</html>